Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Takara Bio Inc (4974)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,010.0 -5.0    -0.49%
07:00:29 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3460200003 
  • Volume: 123,000
  • Bid/Ask: 1,008.0 / 1,010.0
  • Day's Range: 1,000.0 - 1,020.0
Takara Bio 1,010.0 -5.0 -0.49%

4974 Balance Sheet

 
Featured here, the Balance Sheet for Takara Bio Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 61947 62285 69046 77569
Cash and Short Term Investments 35340 38412 46007 51847
Cash - - - -
Cash & Equivalents 35340 38412 46007 51847
Short Term Investments - 2347 2189 2789
Total Receivables, Net 8377 9310 9319 12448
Accounts Receivables - Trade, Net 8377 9310 9319 12448
Total Inventory 13618 11854 11331 11087
Prepaid Expenses - - - -
Other Current Assets, Total 4612 2709 2389 2187
Total Assets 123087 123283 120662 129202
Property/Plant/Equipment, Total - Net 50475 50308 41255 40956
Property/Plant/Equipment, Total - Gross - 70846 60734 59555
Accumulated Depreciation, Total - -20537 -19480 -18600
Goodwill, Net 7013 6963 6565 6674
Intangibles, Net 1816 2087 2171 2373
Long Term Investments - 1639 1624 560
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1 1 1 3
Other Assets, Total 9853 5253 4401 1893
Total Current Liabilities 8317 8922 10263 14375
Accounts Payable 3776 2061 916 2323
Payable/Accrued - - - -
Accrued Expenses 870 933 1325 1065
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - 151
Other Current liabilities, Total 3671 5928 8022 10836
Total Liabilities 10559 11154 12456 16749
Total Long Term Debt - - - 821
Long Term Debt - - - -
Capital Lease Obligations - - - 821
Deferred Income Tax - - - 179
Minority Interest 287 274 251 235
Other Liabilities, Total 1955 1958 1942 1139
Total Equity 112528 112129 108206 112453
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 14965 14965 14965 14965
Additional Paid-In Capital 32893 32893 32893 32893
Retained Earnings (Accumulated Deficit) 52144 53074 52309 57047
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 12526 11197 8039 7548
Total Liabilities & Shareholders' Equity 123087 123283 120662 129202
Total Common Shares Outstanding 120.42 120.42 120.42 120.42
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4974 Comments

Write your thoughts about Takara Bio Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email